The label contraindicates semaglutide in anyone with a personal or family history of MTC or with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Considering the high potency of ecnoglutide, it might also serve as a viable option for individuals who do not achieve sufficient weight reduction with existing GLP-1 receptor agonists at their approved doses or need to achieve a larger reduction in bodyweight, Ji added
Instead, the key is planned monitoring
and professor at Case Western Reserve University School of Medicine Richard Siegel, MD, co-director of the Diabetes and Lipid Center at Tufts Medical Center in Boston
While the FDA approved doses of 0.5 mg and 1.0 mg for diabetes management, the agency has also issued warnings about potential risks including pancreatitis, thyroid cancer concerns based on animal studies, and other serious adverse events
Ozempic reduces calorie and nutrient intake through appetite suppression, which limits the energy and protein available for muscle repair after exercise